Neal Shore, MD, FACS

Most Recent Articles by Neal Shore, MD, FACS

Review of CHAARTED Trial Results

Review of CHAARTED Trial Results

By

CTA Advisory Board member, Neal Shore, MD, puts CHAARTED trial results into context.

ChemotherapyAdvisor.com Editorial Board Recommends High-Impact Abstracts from the 2013 Genitourinary Cancers Symposium

ChemotherapyAdvisor.com Editorial Board Recommends High-Impact Abstracts from the 2013 Genitourinary Cancers Symposium

By

Dr. Neal Shore, MD, FACS, of Atlantic Urology Clinics shares his list of recommended abstracts that will be presented at the 2013 Genitourinary Cancers Symposium.

Active Surveillance for Low-Risk Prostate Cancer May Improve Quality of Life

Active Surveillance for Low-Risk Prostate Cancer May Improve Quality of Life

By

In this article, Advisory Board member Neal Shore, MD, FACS, discusses barriers to clinicians recommending active surveillance for men with low-risk prostate cancer.

Case Study: Castrate-Resistant Prostate Cancer

Case Study: Castrate-Resistant Prostate Cancer

By

Although there are new therapies for M1CRPC patients and others pending, ideal sequencing regimen is still not certain.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters